Healthcare Analytical Testing Services Market: Current Analysis and Forecast (2022-2028)
Global Healthcare Analytical Testing Services Market is expected to grow at a significant rate of around 9% during the forecast period. The analytical testing of bulk drug materials, intermediates, finished pharmaceutical products, drug formulations, contaminants and degradation products, as well as biological samples containing the medications and their metabolites, is crucial in the field of pharmaceutical research. Thus, a rise in research and the development of new drugs, biosimilars, combination products, and other innovative medicines is creating the demand for different specific types of tests which in turn is driving the healthcare analytical testing services market globally. Furthermore, an increasing predominance of the analytical testing rate of biosimilar and biologics, a significant rise in the number of clinical trials and growing adoption of the quality-by-design approach in pharmaceutical research and manufacturing are some of the prominent factors contributing to the growth of the market.
Eurofins Scientific, Charles River Laboratories, Thermo Fisher Scientific, Merck KGAA, Danaher Corporation, Sartorius AG, Syneos Health, Almac Group, WuXi AppTec Co. Ltd., SGS S.A. are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.
Insights Presented in the Report
"Amongst type, bioanalytical testing services category to witness higher CAGR during the forecast period”
Based on the type, the healthcare analytical testing services market is segmented into bioanalytical testing services, physical characterization services, method development & validation testing services, raw material testing services, batch-release testing service, stability testing, microbial testing services, and environmental monitoring services. The bioanalytical testing services segment accounted for a significant market share in 2020 and it is estimated that it will grow rapidly during the projected timeframe as the utility of this service controls the cost of drug development.
"Amongst end-user, the pharmaceutical & biopharmaceutical companies to hold a significant share in the market in 2020”
Based on end-user, the market is fragmented into pharmaceutical & biopharmaceutical companies, medical device companies, and clinical research organizations. The pharmaceutical & biopharmaceutical companies segment is expected to grab a considerable market share in 2020 and is expected to grow with a lucrative CAGR during the forecast period as these businesses have a sizable need for analytical testing to support the numerous manufacturing and marketing operations, clinical trials, medication discovery, and drug development procedures.
"North America to hold a significant share in the market”
For a better understanding of the market adoption of the healthcare analytical testing services industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is anticipated to grow at a substantial CAGR during the forecast period. The major factors such as well-established healthcare infrastructure, the presence of a number of top pharmaceutical and biopharmaceutical companies in the region, high investments in the biosimilars & biologics segment, and increasing R&D expenditure.
Reasons to buy this report:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook